JU Open Plus

What does it take to move beyond the limitations of traditional urinary diversion? In this comment, the author examines the balance between the proven benefits and significant complications of gut-based bladder reconstruction while exploring innovations like tissue engineering and transplantation. It also highlights the key challenges and ethical considerations shaping the future of bladder replacement. 🔗 Click to read more: bit.ly/4wwhFD6

What if bladder reconstruction didn’t have to rely on intestinal tissue and its complications? In this article, the authors review current urinary diversion techniques and emerging innovations like tissue engineering aimed at improving outcomes. They also outline key challenges that must be addressed to advance safer, more effective bladder replacement options. 🔗 Click to read more: bit.ly/4tuWmPm

The April issue of JU Open Plus is here! Explore the latest in open access urological research—available to read now and free to all. As a “gold” Open Access journal, every article is immediately accessible without restrictions. 📚 🔗 Click the link to read the amazing articles today: bit.ly/4fw4MQr

The bladder doesn’t exist in isolation. This letter argues that urinary health reflects an interconnected gut–vagina–bladder axis, shaped by diet, environment, hormones, and antibiotics—suggesting cranberry’s effects on the urobiome may be indirect and reinforcing the need to move beyond organ‑centric thinking in urology. 🔗 Click to read more: bit.ly/41hNnp7

Prostate cancer risk assessment must keep pace with imaging advances. This editorial underscores the value of spatial tumor burden from MRI‑fusion biopsy, arguing that metrics like cancer‑involved regions offer deeper biological insight than traditional measures—and should play a larger role in guiding treatment decisions. 🔗 Click to read more: bit.ly/3OpvQsa

Can prostate biopsies predict surgical risk more accurately? 🔍 New research shows that counting cancer‑involved regions on MRI‑fusion biopsy helps identify patients at higher risk of adverse pathology after prostatectomy—offering a smarter way to guide treatment decisions in the MRI era. 🔗 Click to read more: bit.ly/4sUrVTc

Equity remains the missing piece in kidney cancer care. This editorial stresses that persistent racial and ethnic gaps in partial nephrectomy and robotic surgery are driven by insurance, socioeconomic barriers, and where patients receive care—underscoring the need for systemic fixes, not just advanced technology. 🔗 Click to read more: bit.ly/4vfyK3n

Who gets access to the most advanced kidney cancer surgeries—and who doesn’t? A new national study shows Black and Hispanic patients are less likely to receive robotic-assisted and kidney-sparing surgery for renal cell carcinoma, even as these options become standard across tumor stages. Medical innovation is advancing—but equitable access is not keeping pace. 🔗 Click to read more: bit.ly/3NYc3jv

🚀 Space changes more than gravity—it may reshape the urinary microbiome. This editorial highlights early evidence that spaceflight alters urinary microbiota, while underscoring the real takeaway: small, short‑mission studies are just the start. Longer missions, chemical + microbiome analysis, and greater inclusion of female astronauts are critical to understanding long‑term health risks in space. 🔗 Click to read more: bit.ly/4d1Kgc5

🚀 What happens to the urinary microbiome in space? New research from a short ISS mission shows spaceflight significantly alters urinary microbiota—changes that reverse after return to Earth—raising important questions about astronaut health on future missions. 🔗 Read more: bit.ly/40Q69Ul

Rethinking dysfunctional voiding treatment in young men. This editorial highlights a key shift: pairing pelvic floor physical therapy with baclofen shows promise in improving voiding by better relaxing the pelvic floor—but stresses the need for randomized trials to confirm whether medication truly adds benefit beyond therapy alone. 🔗 Click to read more: bit.ly/3PtDaDl

Trouble voiding in young men doesn’t have to mean invasive care. New research shows a conservative combo—oral baclofen plus pelvic‑floor muscle training—significantly improves symptoms and urinary flow in young adult men with dysfunctional voiding, with no major safety concerns. 🔗 Click to read more: bit.ly/3PtyOMz

The November issue of JU Open Plus is here! Explore the latest in open access urological research—available to read now and free to all. As a “gold” Open Access journal, every article is immediately accessible without restrictions. 📚 🔗 Click to read the amazing articles today: bit.ly/4fw4MQr

📊 Who’s shaping the future of urology fellowships? New AUA match data (2014–2025) show a marked rise in women matching into urology subspecialty fellowships—driven by oncology, endourology, and reconstructive surgery—while trends vary by subspecialty, highlighting where progress is accelerating and where gaps remain. 🔗 Click to read more: bit.ly/4dEDJnO

A routine lab value may be quietly shaping surgical recovery. Thank you @BogdanaSchmidt for your insights into, "Serum Albumin Levels Are Independently Associated With Length of Stay and Readmission in Patients With Renal Cell Carcinoma" which highlights how lower preoperative serum albumin independently predicts longer hospital stays and higher 90‑day readmission risk—highlighting nutrition as a powerful, actionable factor in perioperative care. 🔗 Click to read more: bit.ly/4ldsW5T

❤️ Heart health matters in prostate cancer care. New real‑world data show men starting ADT with diabetes, hypertension, or high cholesterol—especially all three—face a sharply higher risk of cardiovascular events. A simple comorbidity check could help flag risk before treatment begins. 🔗 Click to read more: bit.ly/40L78VX

Better biomarkers—now what about MRI? This editorial underscores that combining blood (Phi) and urine (PCA3 + TMPRSS2:ERG) biomarkers improves detection of clinically significant prostate cancer—but emphasizes the next step: integrating these tools with pre‑biopsy MRI to better target who truly needs a biopsy. 🔗 Click to read more: bit.ly/4c1qhZZ

Fewer biopsies. Better answers. New multicenter research shows that combining a blood test (Phi) with urine biomarkers (PCA3 + TMPRSS2:ERG) significantly improves detection of clinically significant prostate cancer—helping identify aggressive disease while reducing unnecessary biopsies. 🔗 Click to read more: bit.ly/4uNNRRq

What if a simple urine test could help guide long‑term UTI prevention? Most postmenopausal women—regardless of UTI history—have urine pH levels compatible with methenamine therapy. In this study, about three‑quarters of women with current or prior uncomplicated rUTIs had a urine pH ≤6, supporting Hiprex as a practical, antibiotic‑sparing option for long‑term UTI prevention. 🔗 Click to read more: bit.ly/3NK63ux

In this comment, the authors show how a single, routine lab value can help identify kidney cancer patients at risk for longer hospital stays and readmission, highlighting serum albumin’s potential role in perioperative risk stratification—while urging caution before its standalone use. 🔗 Click to read more: bit.ly/4cSkyGS